Business Description
Grifols SA
NAICS : 325412
ISIN : ES0171996087
Share Class Description:
WBO:GRF: Ordinary Shares - Class ADescription
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.21 | |||||
| Equity-to-Asset | 0.25 | |||||
| Debt-to-Equity | 1.9 | |||||
| Debt-to-EBITDA | 14.85 | |||||
| Interest Coverage | 1.34 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.9 | |||||
| Beneish M-Score | -2.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.6 | |||||
| 3-Year EBITDA Growth Rate | -5.7 | |||||
| 3-Year EPS without NRI Growth Rate | -45 | |||||
| 3-Year Book Growth Rate | 4.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 41.31 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 4.03 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 84.79 | |||||
| 9-Day RSI | 77.41 | |||||
| 14-Day RSI | 71.67 | |||||
| 6-1 Month Momentum % | 8.07 | |||||
| 12-1 Month Momentum % | -15.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.68 | |||||
| Quick Ratio | 0.8 | |||||
| Cash Ratio | 0.55 | |||||
| Days Inventory | 396.88 | |||||
| Days Sales Outstanding | 54.32 | |||||
| Days Payable | 96.65 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.3 | |||||
| Shareholder Yield % | -3.74 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 38.42 | |||||
| Operating Margin % | 11.46 | |||||
| Net Margin % | 2.52 | |||||
| FCF Margin % | -1.68 | |||||
| ROE % | 2.23 | |||||
| ROA % | 0.6 | |||||
| ROIC % | 2.12 | |||||
| 3-Year ROIIC % | -3.35 | |||||
| ROC (Joel Greenblatt) % | 10.09 | |||||
| ROCE % | 3.73 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 58.58 | |||||
| Forward PE Ratio | 16.48 | |||||
| PE Ratio without NRI | 101.18 | |||||
| Shiller PE Ratio | 13.4 | |||||
| PS Ratio | 1.5 | |||||
| PB Ratio | 1.35 | |||||
| Price-to-Operating-Cash-Flow | 36.37 | |||||
| EV-to-EBIT | 21.51 | |||||
| EV-to-Forward-EBIT | 15.12 | |||||
| EV-to-EBITDA | 21.51 | |||||
| EV-to-Forward-EBITDA | 10.4 | |||||
| EV-to-Revenue | 2.97 | |||||
| EV-to-Forward-Revenue | 2.13 | |||||
| EV-to-FCF | -176.81 | |||||
| Price-to-Projected-FCF | 1.1 | |||||
| Price-to-Median-PS-Value | 0.42 | |||||
| Earnings Yield (Greenblatt) % | 4.65 | |||||
| FCF Yield % | -1.24 | |||||
| Forward Rate of Return (Yacktman) % | -14.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Grifols SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 5,184.938 | ||
| EPS (TTM) (€) | 0.19 | ||
| Beta | 0.79 | ||
| Volatility % | 57.48 | ||
| 14-Day RSI | 71.67 | ||
| 14-Day ATR (€) | 0.235691 | ||
| 20-Day SMA (€) | 10.184 | ||
| 12-1 Month Momentum % | -15.54 | ||
| 52-Week Range (€) | 6.576 - 15.505 | ||
| Shares Outstanding (Mil) | 679.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Grifols SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Grifols SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Grifols SA Frequently Asked Questions
What is Grifols SA(WBO:GRF)'s stock price today?
The current price of WBO:GRF is €11.16. The 52 week high of WBO:GRF is €15.51 and 52 week low is €6.58.
When is next earnings date of Grifols SA(WBO:GRF)?
The next earnings date of Grifols SA(WBO:GRF) is 2025-02-28 Est..
Does Grifols SA(WBO:GRF) pay dividends? If so, how much?
Grifols SA(WBO:GRF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers